| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/10/2009 | US20090304727 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies |
| 12/10/2009 | US20090304725 Vaccine and Antigen Mimotopes Against Cancerous Diseases Associated with the Carcinoembryonic Antigen CEA |
| 12/10/2009 | US20090304722 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 12/10/2009 | US20090304719 Activatable binding polypeptides and methods of identification and use thereof |
| 12/10/2009 | US20090304713 Binding agents |
| 12/10/2009 | US20090304703 Compositions and methods for the diagnosis and treatment of immune disorders |
| 12/10/2009 | US20090304702 Gene expressed in prostate cancer and methods of use |
| 12/10/2009 | US20090304701 Antibodies binding il-1 related polypeptides |
| 12/10/2009 | US20090304698 Modulation of ovulation |
| 12/10/2009 | US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein |
| 12/10/2009 | US20090304660 G-csf derivative for inducing immunological tolerance |
| 12/10/2009 | US20090304657 Chimeric t cell receptors and related materials and methods of use |
| 12/10/2009 | US20090304653 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 12/10/2009 | US20090304651 Insulin-Like Growth Factor II (IGF-II) Binding Factors |
| 12/10/2009 | US20090304588 Biologically excitable cells |
| 12/10/2009 | US20090304577 Peptides for Treatment and Diagnosis of Autoimmune Disease |
| 12/10/2009 | US20090303461 Detection of enhanced multiplex signals by surface enhanced raman spectroscopy (sers) |
| 12/10/2009 | DE102008002210A1 Verfahren zur fermentativen Herstellung von Erythropoietin A process for the fermentative production of erythropoietin |
| 12/10/2009 | DE102008002209A1 Verfahren zur Aufreinigung von Erythropoietin A process for the purification of erythropoietin |
| 12/10/2009 | CA2727042A1 Method for purifying erythropoietin |
| 12/10/2009 | CA2726942A1 Fviii muteins for treatment of von willebrand disease |
| 12/10/2009 | CA2726914A1 A vaccine for the prevention and therapy of hcv infections |
| 12/10/2009 | CA2726903A1 Long-acting glp-1 derivatives, and methods of treating cardiac dysfunction |
| 12/10/2009 | CA2726804A1 Xbp1, cd138, and cs1 peptides |
| 12/10/2009 | CA2726589A1 Fgf21 mutants and uses thereof |
| 12/10/2009 | CA2726511A1 Anti-inflammatory agents |
| 12/10/2009 | CA2726193A1 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 12/10/2009 | CA2726131A1 Expression and assembly of human group c rotavirus-like particles and uses thereof |
| 12/10/2009 | CA2726128A1 Cell line, system and method for optical control of secondary messengers |
| 12/10/2009 | CA2725634A1 Biomarker for assessing response to chymase treatment |
| 12/10/2009 | CA2723999A1 Pestivirus replicons providing an rna-based viral vector system |
| 12/09/2009 | EP2130926A2 Phage microarray profiling of the humoral response to disease |
| 12/09/2009 | EP2130921A2 Vaccine for prevention and treatment of HIV-infection |
| 12/09/2009 | EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 12/09/2009 | EP2130919A1 IL-21 antagonists |
| 12/09/2009 | EP2130912A1 Pestivirus replicons providing an RNA-based viral vector system |
| 12/09/2009 | EP2130840A1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof |
| 12/09/2009 | EP2130839A2 AXMI-027, AXMI-036 and AXMI-038, a family of delta-endotoxin genes and methods for their use |
| 12/09/2009 | EP2130838A2 Zinc finger binding domains for CNN |
| 12/09/2009 | EP2130837A1 Novel nuclear translocation peptide |
| 12/09/2009 | EP2130836A1 Means and methods for producing zinc fingers and concatemers thereof |
| 12/09/2009 | EP2130548A2 Growth Hormone Releasing Peptides |
| 12/09/2009 | EP2130547A1 IL-25 for use in the treatment of inflammatory diseases |
| 12/09/2009 | EP2130049A1 Cartilage intermediate layer protein 2 c1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions |
| 12/09/2009 | EP2129799A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 12/09/2009 | EP2129793A1 Constitutively active mutants of the prolactin receptor |
| 12/09/2009 | EP2129782A1 Modified microorganism |
| 12/09/2009 | EP2129688A2 Compositions and methods for detecting cancers in a subject |
| 12/09/2009 | EP2129687A2 Novel glp-1 fusion peptides, their production and use |
| 12/09/2009 | EP2129686A1 Methods for industrial scale production of therapeutic complement factor h preparations from human plasma |
| 12/09/2009 | EP2129685A2 Over expression of foldases and chaperones improves protein production |
| 12/09/2009 | EP2129684A1 Method of purification of hydrophobic proteins |
| 12/09/2009 | EP2129683A2 Methods and compositions for the treatment of heart failure and other disorders |
| 12/09/2009 | EP2129359A2 Chimeric peptide antagonist for gpcr135 or gpcr142 |
| 12/09/2009 | EP1673625B1 Generation of stabilized proteins by combinatorial consensus mutagenesis |
| 12/09/2009 | EP1651264B1 Subunit vaccine against respiratory syncytial virus infection |
| 12/09/2009 | EP1472282B1 Use of calmodulin to promote bone regeneration |
| 12/09/2009 | EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 12/09/2009 | EP1404368B1 Mutant forms of cholera holotoxin as an adjuvant |
| 12/09/2009 | EP1165755B1 Banana and melon promoters for expression of transgenes in plants |
| 12/09/2009 | EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 12/09/2009 | EP1040198B1 Recombinant rhabdovirus containing a heterologous fusion protein |
| 12/09/2009 | EP0959905B1 Polysaccharide-peptide-conjugates |
| 12/09/2009 | EP0912724B1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 12/09/2009 | CN101600801A Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 12/09/2009 | CN101600735A Truncated PTH peptides with a cyclic conformation |
| 12/09/2009 | CN101600734A Coding genes with a single exon for new bioactive peptides |
| 12/09/2009 | CN101600732A MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease |
| 12/09/2009 | CN101600731A Aquaretic and natriuretic polypeptides lacking vasodilatory activity |
| 12/09/2009 | CN101600728A Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
| 12/09/2009 | CN101600456A Methods and compositions for treating and monitoring treatment of IL-13-associated disorders |
| 12/09/2009 | CN101600451A Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 12/09/2009 | CN101600449A WNT antagonists and their use in the diagnosis and treatment of WNT-mediated disorders |
| 12/09/2009 | CN101597613A Gene for mediating drug resistance of vancomycin and application thereof |
| 12/09/2009 | CN101597612A SEC2 mutant gene with increased activity of super-antigen and preparation method thereof |
| 12/09/2009 | CN101597609A Monstera deliciosa agglutinin gene and encoded protein and application thereof |
| 12/09/2009 | CN101597608A Human orphan g protein-coupled receptors |
| 12/09/2009 | CN101597332A Preparation method of potato aspartic proteinase inhibitor |
| 12/09/2009 | CN101597331A Salbutamol artificial antigen and preparation method and application thereof |
| 12/09/2009 | CN101597330A Synthesis method of ractopamine artificial antigen |
| 12/09/2009 | CN101597329A Transcription factor relevant with vegetable fatty acid and oil metabolism as well as encoding gene and application thereof |
| 12/09/2009 | CN101597328A Transcription factor for enhancing embryogenesis of plant cell and synthesis of fatty acid as well as encoding gene and application thereof |
| 12/09/2009 | CN101597267A Melamine hapten, antigen and preparation method and applications thereof |
| 12/09/2009 | CN101597266A Synthesis of nickel-ion artificial antigen chelant and preparation of nickel monoclonal antibody |
| 12/09/2009 | CN101597233A Methamphetamine monoclonal antibody kit having no cross-reactions with ephedrine and pseudoephedrine |
| 12/09/2009 | CN100567501C Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 12/09/2009 | CN100567496C Immunization of fish with plant-expressed recombinant proteins |
| 12/09/2009 | CN100567493C Seed plants characterized by delayed seed dispersal |
| 12/09/2009 | CN100567492C Sheep coenurus skrjabini specific gene and its separation and identification |
| 12/09/2009 | CN100567488C Enhancement of virus-mediated DNA transfer |
| 12/09/2009 | CN100567487C Coagulation factor VII derivatives |
| 12/09/2009 | CN100567322C Polypeptide for inhibiting growth differentiation factor activity and cell expressing the same |
| 12/09/2009 | CN100567321C Oxidoreductase from pichia capsulata |
| 12/09/2009 | CN100566753C A hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 12/09/2009 | CN100566697C Silk soap bar and processes for manufacture the same |
| 12/08/2009 | US7630838 Method for identifying agents that interact with beta-site APP cleaving enzyme (BACE) |
| 12/08/2009 | US7630836 Polynucleotides |
| 12/08/2009 | US7629518 Plants and seeds of hybrid corn variety CH923156 |
| 12/08/2009 | US7629504 Bacillus thuringiensis cry9 nucleic acids |
| 12/08/2009 | US7629453 NF-κB activating gene |